Towards an Ethics Management System for Biotechnology

1 minute read

Author: Marc Saner

Originally prepared for the Interdepartmental Working Group on Ethics and Public Confidence in Biotechnology, this paper argues that governments should consider ethical issues not only at the regulatory stage of biotech products, but during the entire product life cycle. The article develops a framework to identify the life cycle stage at which various ethical issues could be addressed and the sectors that could have a role in addressing these issues. The report will be published in a special 2005 ethics edition of the International Journal for Risk Assessment and Management.

About the author

Institute on Governance

Institute on Governance

Founded in 1990, the Institute on Governance (IOG) is an independent, Canada-based, not-for-profit public interest institution with its head office in Ottawa and an office in Toronto. Our mission is ‘advancing better governance in the public interest,’ which we accomplish by exploring, developing and promoting the principles, standards and practices which underlie good governance in the public sphere, both in Canada and abroad.

(613) 562-0090 or 0092